Objective To detect antibodies for lens bH-crystallins in the serum from the American Cocker Spaniel (ACS) presenting with and without cataracts and with and without uveitis. Animal Studied Seventy-three American Cocker Spaniels and six normal Beagles. Procedures Sera were collected from 73 ACSs, including those with normal lenses and those with cataracts, or uveitis. Fractionated, normal Beagle lens bH-crystallins were separated by one-or two-dimensional electrophoresis. The separated lens bH-crystallins were used on immunoblots as sentinel substrates against which the ACS sera were tested for the presence of antibodies against bH-crystallins. Results Sera from approximately two-thirds of study animals contained antibodies to some bH-crystallin polypeptides, but reactivity varied among patients. Contrary to some hypotheses, serum antibodies to groups of bH-crystallins did not relate to the stages of cataract. However, detailed analysis by two-dimensional immunoblotting and mass spectrometry showed that three spots originating from bA1-crystallin were detected only in sera from cataract patients. Conclusion Serum antibodies to bA1-crystallin may be associated with the development of cataract.
INTRODUCTION
Cataracts are a leading cause of poor visual acuity and blindness in dogs. A retrospective study reported significantly higher odds ratios for cataracts in six pure-bred dogs (including cocker spaniel, miniature schnauzer, toy poodle, Boston terrier, miniature poodle, and bichon frise) compared with mixed-breed dogs. 1 For example, the American Cocker Spaniel (ACS) was reported in North America to have a prevalence of cataract of 8.8% during the period of 1964-2003, 2 and similar prevalence (7.8%) was also reported in Brazil during the period of [2005] [2006] [2007] [2008] . 3 Risk factors for cataract include the following: congenital defects, advancing age, genetic background, diabetes mellitus, uveitis, hypocalcemia, electric shock, and exposure to radiation or toxic substances, such as dinitrophenol and naphthalene. 4, 5 Postulated mechanisms for cataract formation include the following: (i) action of reactive oxygen species leading to breakdown of lens plasma membranes, (ii) loss of ion homeostasis and accumulation of sodium and calcium in lens, and (iii) post-translational modifications of the major structural proteins of the lens (a-, b-, and c-crystallins) leading to their insolubilization and opacity. [6] [7] [8] [9] [10] [11] Postdevelopmental modifications, include truncation, phosphorylation, and deamidation. Another postulated mechanism is that the plasma membranes of the lens leak crystallins into the anterior chamber and systemic circulation, causing an autoimmune reaction to lens proteins, cataract formation, and uveitis. 12 As this latter mechanism is controversial, the purpose of this study was to determine the relationship between serum antibodies to bH-crystallins and the stage of cataract in ACS. We focused on the b-crystallins because they are one of the most abundant components of the insolubilized, cataractous lens proteins. 13, 14 Although nonlenticular tissues (e.g., retina) may express low levels, the lens contains the highest concentration of b-crystallins. 17 Both eyes were scored for cataracts, and only data from the eye with the cataract in the most advanced stage were reported. Uveitis was also scored by observing conjunctival hyperemia, iris appearance and aqueous flare, as modified previously by Park, et al. 18 Score 0 was defined as no conjunctival hyperemia, no iris hyperplasia or atrophy, and no aqueous flare; score 1 was defined as mild conjunctival hyperemia, mild iris hyperplasia or atrophy, but no aqueous flare; score 2 was defined as moderate conjunctival hyperemia, moderate iris hyperplasia or atrophy (possible darkening of the iris), and no or mild aqueous flare; and score 3 was defined as severe conjunctival hyperemia, severe iris hyperplasia or atrophy, and moderate aqueous flare.
Isolation and purification of lens proteins
Frozen lenses obtained from six 2-year-old Beagles were homogenized, and total water-soluble lens proteins were collected after centrifugation. Lens crystallins were fractionated using Sepharose CL-6B gel filtration. Groups of bH-crystallins, termed H1, H2, H3, and H4, were further separated using 12.5% SDS-polyacrylamide gel electrophoresis using a Mini-PROTEAN â Tetra cell (Bio-Rad Laboratories, Inc., Tokyo, Japan). These bHcrystallins were used as sentinel proteins for detecting serum antibodies described in the following sections because of previous comparative literature data, 19 the known masses and migration positions of the seven separate gene products for b-crystallins polypeptides on electrophoresis, and the propensity of b-crystallins to become modified and precipitate in experimental cataract. 13, 20 Detection of serum antibody reactivity by immunoblotting bH-crystallins separated by SDS-PAGE gels were electrotransferred to polyvinylidene difluoride (PVDF) membrane at 50 V for 90 min at a ice-cold temperature using Trisglycine buffer (25 mM Tris, 192 mM glycine, 20% methanol), using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories, Inc.). Sera from 73 ACSs were obtained by venipuncture, stored at À80°C, and flooded over the PVDF membrane at 1:200 dilution in 1% skim milk in Tris-Buffered Saline Tween 20. 21 Immunoreactivity was visualized with 3, 3', 5, 5′-tetramethylbenzidine and horseradish peroxidase conjugated to anti-rabbit IgG secondary antibody. A positive reaction was reported if staining was more intense than the negative control immunoblot reacted with the secondary antibody but no sera.
Two-dimensional electrophoresis and mass spectrographic analysis
Protein spots on the membrane were analyzed using the IMAGEJ (NIH) software. The molecular weights (MW) and isoelectric points (IP) of spots were estimated in triplicate using molecular weight markers (SDS7; Sigma) and 2-D SDS-PAGE standards (Bio-Rad). After the preparative gels were stained with Coomassie brilliant blue R-250 (Merck KGaA, Darmstadt, Germany), protein spots of interest were excised from the gels and digested with trypsin. The tryptic peptides were extracted and dried completely by centrifugal lyophilization. The peptides were analyzed by matrix-assisted laser desorption/ionization-time of flighttandem mass spectrometry (MALDITOF-MS), performed using a Voyager-DE STR (Life Technologies, Tokyo, Japan). Mass spectra were used to search canine sequences in the NCBI nr database using the Mascot database search algorithms.
Statistical analysis
Statistical evaluations were performed with a commercially available software program (JMP10.0.2 statistical software; SAS Institute, Tokyo, Japan). The relationship between age and stage of cataract was evaluated by Spearman's rank correlation coefficient. Correlation between the incidence of bH-crystallins antibodies in sera and stages of cataract or uveitis were assessed by Pearson's v
RE SUL TS
Evaluations of 73 ACS dogs found 12 with both lenses normal, three dogs with at least one lens with immature cataracts, 32 dogs contained mature cataracts, and 15 had hypermature cataracts (Fig. 1a) . Lenses in 11 dogs could not be observed due to corneal opacity due to ocular surface abnormalities or glaucoma; these dogs were excluded from further analysis. To maintain statistical validity, the data from the very small group of patients with immature cataracts were also eliminated. The stage of cataract was found to be negatively correlated with age in our patient population (P = 0.0054, Fig. 1b) .
In addition to cataract, uveitis was the major ocular disease in our study patients (Table 1a) . Uveitis developed concomitantly with cataract, and this might be a reason why anti-inflammatory drugs were used in mature and hypermature cataract patients (Table 1b) .
Purification of dog lens crystallins yielded the four known major peaks 22 for a-, bH-, bL, and c-crystallins (data not shown), which contained several bands of crystallins (Fig. 2a) . The polypeptides within the bH-crystallin group are comprised of seven separate gene products and their fragments, 20 and four arbitrary groupings of these protein bands (termed H1, H2, H3, and H4) based on their common range of MW's were used in a one-dimensional immunoblot assay for serum anti-bH-crystallin reactivity (Fig. 2b) . No serum antibodies for any bH-crystallin were detected in approximately 30-40% of patients despite the existence of opacity (Fig. 3a, column '0' ). This was highest frequency in the largest group with hypermature cataract (Fig. 3a, column '0', open bar) . The group of patients with the highest frequency of mature cataracts (~40%), and the group with highest frequency of normal lenses (~50%) contained 2 and 3 kinds of antibodies for bH-crystallins, respectively. Serum antibody reactivity to groups of bH-crystallin polypeptides varied between groups of cataract patients (Fig. 3b) .The incidence of serum antibodies against bH-crystallins in ACSs was not positively related to stages of cataract (Fig. 3b) . Indeed, serum antibody reactivity against the b-crystallin H4 group was negatively correlated with stage of cataract (P = 0.032, Fig. 3b, H4*) . Thus, the data do not confirm a positive relationship between serum bH-crystallin antibodies and stage of cataract.
Patients with cataract were also exhibited uveitis (Fig. 3c , 'Mature' and 'Hypermature'). The stage of uveitis was not different between patients with mature and hypermature cataracts.
Patients with normal lenses did not develop uveitis (Fig. 3c , 'Normal'). As with cataract, the stage of uveitis was negatively correlated with serum antibody reactivity against the b-crystallin H4 group (P = 0.025, Fig. 3d, H4*) .
Protein staining on the two-dimensional proteome map of noncataractous Beagle bH lens crystallins detected 14 protein individual spots (Fig. 4a) , varying in molecular weight from 22 to 27 kDa and ranging in IP from 5.4 to 6.4. After destaining these protein spots, immunoblot assays for serum bH-crystallin antibody activities in ACS dogs were performed. Antibody to the large amount of landmark Spot 6, identified as bB2-crystallin, was most frequently observed in 11 patients (normal plus cataractous). Interestingly, antibody reactions to spots 1, 5 and 13 were found only in the serum from patients with cataract (Fig. 4b*) and not in normal lenses (gray bars). Mass spectrographic analysis of these three spots indicated that they were from bA1-crystallin (Fig. 5) .
DISCUSSION
A major finding of the present investigation was that serum antibodies to bH-crystallin in ACS dogs were not directly (positively) related to the stage of cataract ( Fig. 3b) . We observed a significant decrease in anti-bH4-crystallin serum reactivity with stage of cataract. As cataract stage was negatively associated with aging (Fig. 1b) , these ACS cataracts were likely due their known genetic propensity for cataract. 2 Due to heredity predilection in some breeds (Canine Inherited Disorders Database; URL http://ic.upei.ca/cidd/breed/cocker-spaniel-american [accessed on 06 September 2013]) show increased risk of certain disorders including cataract. Further, the data do not support a proposed mechanism whereby bH-crystallins leak from lenses due to membrane breakdown into the serum causing a generalized increased autoimmune reaction against lens proteins resulting in cataract. A similar negative correlation between serum antibodies against general lens crystallins and stage of cataract in an unknown species of dog was also reported, 12 and the data supporting a similar autoimmune mechanism for human cataract are conflicted. [23] [24] [25] Another major new finding was presentation of a proteome map for normal, canine bH-crystallins (Fig. 4a) . Features included the predominance of reactivity for the abundant lens crystallin bB2. We noted 14 different polypeptides with differing masses and PI's. As only seven separate gene products exist for the bH-crystallin family, some of the spots were due to degradation and/or protein modifications of the bH-crystallin polypeptides. For example, spots 1, 5 and 13 were only found in sera from dogs with cataractous lenses and showed three masses of 26.9, 22.3, and 23.7 kDa, respectively. These spots were determined to be bA1-crystallin (Fig. 5) , which has a native molecular weight of 22.3 kDa.
The b-crystallin family consists of four acidic (bA1-, bA2-, bA3-, bA4-crystallin) and three basic (bB1-, bB2-, and bB3-crystallin) protein members that form homodimers and then aggregate into complex hetero-oligomers. Heterodimers of b-crystallins increase during aging and cataracts, contributing consequently to the accumulation of insoluble b-crystallins. 11, 26, 27 The production of antibodies against b-crystallins may be related to the instability of dimer formation of b-crystallins.
Increased calcium is present in many types of cataract. 8, 28, 29 Three types of calcium-activated proteases (calpain 1, calpain 2, and Lp82) are present in dog lenses (Y. Tamada, T.R. Shearer, M. Azuma, unpublished data), and we speculate that calpain may have caused increased degradation in ACS cataracts. Thus, while levels of antibodies to groups of bH-crystallins was not related to cataract, release of specific polypeptides, such as bA1-crystallin or its derivatives, may have been increased, and thereby increased serum antibodies to them in ACS cataract. Although more samples are needed, the data suggested that increased reactivity by bA1-crystallin antibodies is associated with cataract formation. If future studies detect anti-bA1-crystallin antibodies at the earlier stages of cataract formation, the antibody may be useful as a prognostic marker for earlier cataract treatment and prevention. This is especially pertinent as bA1-crystallin is one of the most abundant crystallins to be insolubilized in cataractous lenses.
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